Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

JAK inhibitors and COVID-19.

Journal article

Levy G. et al, (2022), Journal for immunotherapy of cancer, 10

Degrading JAK2 in ALL by ruxolitinib-based PROTACs

Journal article

Constantinescu SN. and Pecquet C., (2021), Blood, 138, 2301 - 2302

MPL S505C enhances driver mutations at W515 in essential thrombocythemia.

Journal article

Varghese LN. et al, (2021), Blood cancer journal, 11

Pituitary incidentaloma.

Journal article

Constantinescu SM. and Maiter D., (2021), Presse medicale (Paris, France : 1983)

Functional Consequences of Mutations in Myeloproliferative Neoplasms

Journal article

Constantinescu SN. et al, (2021), HemaSphere

Targets in MPNs and potential therapeutics


Levy G. et al, (2021), International Review of Cell and Molecular Biology